Furthermore, several studies implicated GluA3 gene transcription and protein expression to be associated with cognitive decline in mild cognitively impaired individuals and AD patients (Armstrong et al., 1994; Yasuda et al., 1995; Armstrong and Ikonomovic, 1996; Carter et al., 2004; Bodily et al., 2016; Hondius et al., 2016; Bereczki et al., 2018; Enache et al., 2020; Medina-Vera et al., 2023). The gene discussed is GRIA3; the disease is Alzheimer disease.